SlideShare a Scribd company logo
HAEMOGLOBINOPATHIES:
EMPHASIS ON SCA
BAFFA A GWARAM MPH FMCP
DEPT OF MEDICINE
BUK/AKTH
LEARNING OBJECTIVES
Describe Haemoglobinopathies
Describe the various complications and
types of crisis in SCA and how to identify
them.
Understand the modalities of treatment of
the various crises in our environment.
Understand ways of preventing the crises.
SESSION OUTLINE
Introduction to Haemoglobinopathies
Overview of SCD/SCA
Complications of SCA
Sickle Cell Crisis
Management of SCA crises
Prevention of sickle cell crises
INTRODUCTION
Haemoglobinopathies can be qualitative or
quantitative
Qualitative Hb abnormality due to
alteration in DNA coding leading to an abn
amino acid in the globin molecule
Quantitative Hb disorders result from
imbalance globin chain production
Haemoglobinopathies result in significant
morbidity and mortality on a world wide
scale
INTRODUCTION
The clinical syndromes produced by Hb
abnormalities:
Syndrome Abnormality
Haemolysis Crystalline Hb (S,C,D,E)
Unstable Hb
Thalassaemia α and β
Familial polycythaemia Altered O2 affinity
Methaemoglobinaemia Failure of reduction
INTRODUCTION
Thalassaemias
α Thal - mostly due to gene deletion
Silent α thal- (-α/αα)
α thal trait (αα/-- or -α/-α)
Hb H disease (--/-α)
Hb Bart’s hydrops fetalis (--/--)
INTRODUCTION
β Thal – most are due to single point
mutation
-β+ reduced β globin synthesis
-β0 absent β globin production
Hence;
β thal trait – carrier state
β thal intermedia
β thal major (Cooley’s anaemia)
INTRODUCTION
Crystalline Haemoglobins
Hb S ( glu → val at position 6 )
Hb C ( glu → lys at position 6 )
Hb D ( glu → gln at position 121)
Hb E ( glu → lys at position 26)
Hb O ( glu → lys at position 121)
James B. Africanus Horton
(1835 - 1883)
Nigerian born in Sierra Leone
Qualified from the Medical School
of King’s College London, at 24.
In 1874, first to publish the
features of SCD in his book
‘The Diseases of Tropical
Climates & Their Treatment’.
Research => MD Univ. of Edinburgh
A Colonel in the British Army.
A committed patriot, Horton was
an advocate for the establishment
of universities in West Africa.
James B Herrick
An interesting twist of history
A Chicago Cardiologist
In 1910, published the findings
of
‘Peculiar elongated and
sickled red blood cells in
a case of severe anaemia’.
1st account of pathology of SCD.
Gave SCD the name it bears today.
OVERVIEW OF SCD/ SCA
SCA is due to a point mutation in the β-globin
gene.
HbS differs from normal adult HbA by the
substitution of valine for glutamic acid in the 6th
position of the β-globin chain.
This lead to polymerisation of deoxyHb S and
instability of oxyHb S.
Other abnormalities of β-chain synthesis may be
inherited with Hb S, notably Hb C and the β thal.
severity: Hb SS and HbS/β0 thal > HbSC >
HbS/β+ thal
OVERVIEW OF SCD/ SCA
Hb SS is an example of mendelian
inheritance.
The disease course is significantly
modified by envtal factors and other genes
(β-globin haplotypes, HbF , α thal)
Including genes controlling bilirubin, HTN,
coagulation pathway, vascular cell
adhesion molecule polymorphism,
morphine receptor polymorphism
OVERVIEW OF SCD/ SCA
Epidemiology- Prevalence - 2% of SCA and
20-30% of the gene in Nigeria
High frequency of HbS gene in area where P.
falciparum is/was endemic, and in there
emigrant population.
HbS protects against P. Falciparum by atleast
2 mechanisms
1. Parasites consume O2 within the red cells,
induce sickling and are removed by the RES in
the early stages of erythrocytic cycle.
2. The last 12hrs of the parasite cycle are spent in
deep tissue at low O2 tension
‘‘WE ARE SPECIAL PEOPLE
WITH TOO MUCH OF A
GOOD THING’’
- Hb SS patient
OVERVIEW OF SCD/ SCA
Pathogenesis
When HbS is deoxygenated, the
molecules of Hb polymerise to form
tactoids. This distort the red cell
membrane into sickle shaped cells.
Sickling is initially reversible with
reoxygenation.
The distortion may become permanent
and the red cell ’’irreversibly sickled’’
COMPLICATIONS OF SCA
In the homozygous state (HbSS) causes :-
INFARCTION
HAEMOLYTIC ANAEMIA
That lead to
♦ Increase susceptibility to infections
♦ Disturbance of growth and dev
♦ Chronic organ damage
COMPLICATIONS OF SCA
Chronic anaemia leads to erythroid hyperplasia
and expansion of the bone marrow which
causes sickle cell facie ( bossing, depressed
nasal bridge, gnathopathy).
CVS – Tachycardia, mummurs. Heart is
enlarged invariably after 6yrs
GIT – Mod jaundice and raised serum bil,
deranged LFT and fatty degeneration leading to
liver failure. Pigment gallstones are found in
about 10% of adult Nigerians. Hyposplenism
Eye – Proliferative retinopathy, blindness, retinal
artery occlusion, retinal detachment
Genitourinary – Renal papillary necrosis
leading to hematuria and renal tubular defect.
Inability to concentrate urine, freq UTI in females
and CKD in adults
Locomotor – Avascular necrosis of the head of
the femur or humerus, arthritis, osteomyelitis
and chronic leg ulceration
Pulmonary – chest pain due to pulm infarction,
pneumonia. Chronic lung dx with cor pulmonale
secondary to multiple arteriolar thrombi
COMPLICATIONS OF SCA
Infection – Impaired resistance to bacterial
infection esp Strep. pneumoniae and salmonella
spp because of :-
♦Inadequate opsonization
♦ Hyposplenism
♦ Lesions in skin, mucous memb and tissue
necrosis following infarction
♦ Diminished CMI
Acute viral infection are particularly severe
HIV and Hep B&C infections
COMPLICATIONS OF SCA
CNS – Convulsions, TIAs or strokes,
sensory hearing loss
Psychosocial – Depression ,social
withdrawal, drug addiction
SICKLE CELL CRISIS
Type of sickle cell crisis
Anaemic
Haemolytic
Sequestration
Aplastic
Magaloblastic
Infarctive
SICKLE CELL CRISIS
There are 4 types of anaemic crisis, during
which the Hb concentration falls catastrophically:
♦ Haemolytic crisis cause severe anaemia and
jaundice; they may follow infection e.g malaria,
but often no trigger is identified.
♦ Sequestration crisis occur mainly in children.
There is pooling of large volume of blood in the
spleen or liver. Spleen enlarges dramatically and
the Hb falls precipitously.
♦ Aplastic crisis is as a result of bone marrow
depression by infection- particularly Parvovirus
B19. Severe anaemia develops quickly.
SICKLE CELL CRISIS
♦ Megaloblastic crisis. Almost all
untreated African children with SCA are
folate deficient and more than 10% of
Africans with SCA have megaloblastic
erythropoiesis due to folate deficiency.
SICKLE CELL CRISIS
Infarctive (Vaso-occlusive/Painful) crisis–
Sickle cells do not flow well through small
vessels and are more adherent than
normal to vascular endothelium.
They block the capillaries and cause
infarction, with further endothelial damage
and thrombosis.
Necrosis of infarcted tissue leads to
sudden swelling, severe pain and fever.
SICKLE CELL CRISIS
Infarctive crises are precipitated by factors that
promote the deoxygenation of Hb in the
capillaries, but in many instances no trigger is
identified.
Triggers – Infections, dehydration, exposure to
cold , fatigue and stasis (menstruation).
Dactilitis – In children between 6mths and 2yrs
infarcts occur typically in the small bones of the
hands and feet (in older children or adults the
long bones are affected).
SICKLE CELL CRISIS
Stroke – Infarctive strokes are common in
children while haemorrhagic stroke occur more
in adults.
Acute chest syndrome (ACS) – common cause
of death. Chest wall pain, pleurisy, fever, cough
and SOB. Has infitrates in the lungs. Resemble
infection, infarction or embolism.
Acute Bone Marrow Necrosis - Acute bone
marrow necrosis is now recognized more often
as a complication of sickle cell disease with the
introduction of magnetic resonance imaging
(MRI) techniques.
SICKLE CELL CRISIS
Any tissue of the body can be the site of an infarction:-
♦ Bony infarct (skull, ribs, long bones, spine
and girdle)
♦ Splenic and hepatic infarcts
♦ Pulmonary micro infarcts
♦ Mesenteric infarcts
♦ Cortical or papillary infarcts
Priapism is a potentially serious problem for young men
with sickle cell disease. Priapism lasting more than three
or four hours is a medical emergency since it can
produce impotence.
MANAGEMENT OF SCA CRISES
Ideally patients should carry a sickle cell identity
card.
Take history
Investigate – Hb (?steady state Hb), WCC and
retics, thick and thin smear for MP. Examine
urine and do other tests as indicated.
Give a course of curative anti-malarial and
continue with anti-malarial prophylaxis and folic
acid
MANAGEMENT OF SCA CRISES
Anaemic crisis - Many patients whose Hb has
fallen below their usual steady state level
recover with no more than anti-malarial therapy,
folic acid and antibiotics if indicated.
Blood transfusion is indicated only if:
♦ The patient has respiratory distress
♦ The patient has incipient or actual cardiac failure
♦ There is a sequestration crisis the Hb is <6g/dl
♦ Obstetric delivery is imminent and Hb is < 8g/dl
♦ Major surgery is indicated and the Hb is < 8g/dl
(Donor blood should be Hb AA)
MANAGEMENT OF SCA CRISES
Infarctive crisis –
There is no specific treatment.
♦ Treat the cause if known; give appropriate
antibiotics if infected
♦ Manage pain
♦ Maintain hydration and acid base balance;
replace fluid liberally, either orally or IV
♦ Give O2 to patients with severe chest pain
or pnuemonia
MANAGEMENT OF SCA CRISES
Management of pain
-Severe pain- morphine in full therapeutic dose ±
NSAID or promethazine
-Less severe pain- Dihydrocodeine
-Mild pain- Paracetamol
♦ Assess the severity of pain regularly :adjust
doses accordingly
♦ Never prescribe analgesics ‘as required’
♦ Give supply of PCM for self treatment
♦ Fentanyl patches are excellent for prolonged
moderate to severe pain if available
MANAGEMENT OF SCA CRISES
Patients with SCA and unexplained fever should
be cultured thoroughly. If the clinical condition
suggests septicemia, the best action is to start
broad spectrum antibiotics after complete
culturing.
Signs of systemic infection include fever,
shaking chills, lethargy, malaise, and
hypotension.
Patients with septicemia can expire in only a
few hours. Therefore, observation is not a good
option when sepsis is suspected.
MANAGEMENT OF SCA CRISES
Stroke management includes rehydration and
red cell transfusion, preferably exchange
transfusion with the target of reducing HbS to
30% of total Hb.
ACS requires prompt and vigorous treatment.
Give O2 if pO2 can not be kept above 70mmHg
on air. Treat infection, usually due to S.
pneumoniae, H influenza, Mycoplasma,
Legionella
Exchange transfusion is the treatment of choice
for ACS. The procedure involves exchange of
the total blood volume and is done most
efficiently using an apheresis machine.
MANAGEMENT OF SCA CRISES
The treatment of splenic sequestration crisis
includes intravenous fluids and transfusion as
necessary to maintain the intravascular volume.
A child who suffers one episode of splenic
sequestration crisis is at greater risk of a second
attack .
In hepatic sequestration, Fluids, oxygen and
analgesia are the usual management
interventions taken. The benefit of more
aggressive measures such as exchange
transfusion is unknown.
MANAGEMENT OF SCA CRISES
Patients with bone marrow necrosis often suffer
excruciatingly severe pain. Some patients
require epidural anesthesia for control of
wrenchingly intense pain.
Often, but not always, aplastic crisis coincide
with a painful crisis. The reticulocyte count
should be checked on admission to the hospital
in patients with SCA.
The treatment of aplastic crisis is purely
supportive, with transfusions to maintain an
acceptable hematocrit until marrow activity is
restored.
MANAGEMENT OF SCA CRISES
Priapism- The most commonly used intervention
in the past was irrigation of the ventral vein of
the penis by a urologist in an attempt to remove
the blockage to blood flow.
Surgery often fail to resolve the priapism and
has the risk of inducing impotence.
More recently, exchange transfusion has been
used in some of these patients with mixed
results.
Non-acute cases of priapism are sometimes
treated with conjugated estrogens or
vasodilators.
PREVENTION OF CRISES
Counseling
Early diagnosis
Education- General public, parents,
guardians, patient, health professionals
Sickle cell clinics
♦ Prevention of infection- anti-malarial
prophylaxis, ITNs, prophylactic oral
penicillin, Pneumococcal vaccine, H
influenza vaccine, all routine vaccines.
PREVENTION OF CRISIS
Sickle cell clinics (cont)
♦ Nutrition- Folic acid and oral zinc
supplements, Gen nutritional advice
♦ Self treatment – PCM
♦ Advice- Avoid triggers of crises, attend clinic
regularly, report when ill and when pregnant
PREVENTION OF CRISIS
Obstetric care –
Prenatal diagnosis
ANC booking early
Anti-malarial
Folic acid
Monitor- Hb, BP, Urine protein
Deliver in hospital
Supervision of puerperium- monitor for
infection
♦ Family limitation- advice not more than two
viable children
PREVENTION OF CRISIS
Recent therapeutic advances
Hydroxyurea
Erythropoietin
Short chain fatty acids-Isobutyramide
Clotrimazole
5-azacytidine
Transcranial doppler
Bone marrow transplantation
Gene therapy
Extended matching for red cell antigens for blood
transfusion
HYDROXYUREA THERAPY
Studies have shown that both sickled
and unsickled RBCs attach to vascular
endothelium using adhesion molecules
So, RBCs also contribute to vaso-occlusion
in SCD through an active process distinct
from passive mechanical obstruction.
Molecules That Mediate RBC Adherence to
Vascular Endothelium.
HYDROXYUREA THERAPY
α5ß3 integrin on vascular endothelium is the ligand
for several RBC adhesion molecules; e.g,
phosphatidylserine, sulfated glycans, CD47 & CD36.
Administration of a monoclonal antibody to α5ß3
integrin abolished vaso-occlusion in a mouse model
with SCD.
Therefore, α5ß3 integrin is a candidate cell adhesion
molecule for targeted reduction or blockage in the
treatment of SCD.
Evidence That WBCs Have A Role In SCD
The Severity of SCD Increases With Neutrophil Count
High WBC Count: A Risk Factor For Early Death
Clinical Improvement During Hydroxyurea Therapy
Coincides with Fall in WBC Count, even without a rise in HbF.
Sickle Cell Crisis & Acute Chest Syndrome Following
Severe Neutrophilia Induced By G-CSF; Resolved As
Hydroxyurea Therapy Brought Down WBC Count.
High Neutrophil Count: A Powerful Predictor of Good
Response to Hydroxyurea
References
Fleming AF,Menedez C: Blood in ;Principleof
medicine in Africa; Parry E et al (editors), 3rd
edition.p 924-70 Cambridge publishing.
Provan D et al (editors):Oxford hand book of
clinical haematology,2nd edition. P72-84 Oxford
publishing
Young NS, Stanton LG, High KA (editors):
Clinical haematology, 2nd edition. Mosby
Elsevier publishing
Halett C et al(editors): Davidson’s principle and
practice of medicine 19th edition. P737-800
Churchill Livingstone publishing
THANK YOU

More Related Content

Similar to Haemoglobinopathies npmc.ppt

Similar to Haemoglobinopathies npmc.ppt (20)

SICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptxSICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptx
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Sickle Cell Anemia
Sickle Cell Anemia Sickle Cell Anemia
Sickle Cell Anemia
 
Sickle cell anemia - By Janaki raman
Sickle cell anemia - By Janaki ramanSickle cell anemia - By Janaki raman
Sickle cell anemia - By Janaki raman
 
Thalassemia and Hemoglobinopathies
Thalassemia and HemoglobinopathiesThalassemia and Hemoglobinopathies
Thalassemia and Hemoglobinopathies
 
SCA
SCA SCA
SCA
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Premarietal counselling (alkhwair)
Premarietal counselling (alkhwair)Premarietal counselling (alkhwair)
Premarietal counselling (alkhwair)
 
Sickle Cell Anemia
Sickle Cell AnemiaSickle Cell Anemia
Sickle Cell Anemia
 
Hematology reivew 4.pptx
Hematology reivew 4.pptxHematology reivew 4.pptx
Hematology reivew 4.pptx
 
Anemia Ped 5th yr1 (1).pdf
Anemia Ped 5th yr1 (1).pdfAnemia Ped 5th yr1 (1).pdf
Anemia Ped 5th yr1 (1).pdf
 
New sickle copy
New sickle   copyNew sickle   copy
New sickle copy
 
Anemia
AnemiaAnemia
Anemia
 
Pathology of blood
Pathology of bloodPathology of blood
Pathology of blood
 
Thalasemia
ThalasemiaThalasemia
Thalasemia
 
Sicklecell
SicklecellSicklecell
Sicklecell
 
Sickle cell
Sickle cell Sickle cell
Sickle cell
 
Anemia
AnemiaAnemia
Anemia
 
Sickle Cell Anemia.ppt
Sickle Cell Anemia.pptSickle Cell Anemia.ppt
Sickle Cell Anemia.ppt
 
Haematological disorders.pptx
Haematological disorders.pptxHaematological disorders.pptx
Haematological disorders.pptx
 

More from Kemi Adaramola

More from Kemi Adaramola (20)

Renal Function Tests 2010.ppt
Renal Function Tests 2010.pptRenal Function Tests 2010.ppt
Renal Function Tests 2010.ppt
 
HYPOGLYCAEMIC AGENTS{ANTI DIABETIC DRUGS}2.ppt
HYPOGLYCAEMIC AGENTS{ANTI DIABETIC DRUGS}2.pptHYPOGLYCAEMIC AGENTS{ANTI DIABETIC DRUGS}2.ppt
HYPOGLYCAEMIC AGENTS{ANTI DIABETIC DRUGS}2.ppt
 
basic principles of ECHO.ppt
basic principles of ECHO.pptbasic principles of ECHO.ppt
basic principles of ECHO.ppt
 
DISEASES OF THE THYROID GLAND NOVEMBER 2018.pptx
DISEASES OF THE THYROID GLAND NOVEMBER  2018.pptxDISEASES OF THE THYROID GLAND NOVEMBER  2018.pptx
DISEASES OF THE THYROID GLAND NOVEMBER 2018.pptx
 
Diabetes mellitus in children.pptx
Diabetes mellitus in children.pptxDiabetes mellitus in children.pptx
Diabetes mellitus in children.pptx
 
DEFIBRILLATION.pptx
DEFIBRILLATION.pptxDEFIBRILLATION.pptx
DEFIBRILLATION.pptx
 
PULMONARYHYPERTENSION IN HEART FAILURE.pptx
PULMONARYHYPERTENSION IN HEART FAILURE.pptxPULMONARYHYPERTENSION IN HEART FAILURE.pptx
PULMONARYHYPERTENSION IN HEART FAILURE.pptx
 
ADDISONIAN CRISIS 2.pptx
ADDISONIAN CRISIS 2.pptxADDISONIAN CRISIS 2.pptx
ADDISONIAN CRISIS 2.pptx
 
pulmo HTN.pptx
pulmo HTN.pptxpulmo HTN.pptx
pulmo HTN.pptx
 
NEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptxNEW CARDIOVASCULAR RISK FACTORS.pptx
NEW CARDIOVASCULAR RISK FACTORS.pptx
 
Management of ascites(3).pptx
Management of ascites(3).pptxManagement of ascites(3).pptx
Management of ascites(3).pptx
 
SUPPRATIVE LUNG DISEASES.pptx
SUPPRATIVE LUNG DISEASES.pptxSUPPRATIVE LUNG DISEASES.pptx
SUPPRATIVE LUNG DISEASES.pptx
 
Pyodermas by Essen .pptx
Pyodermas by Essen .pptxPyodermas by Essen .pptx
Pyodermas by Essen .pptx
 
ACUTE LEUKAEMIAS IN ADULTS.pptx
ACUTE LEUKAEMIAS IN ADULTS.pptxACUTE LEUKAEMIAS IN ADULTS.pptx
ACUTE LEUKAEMIAS IN ADULTS.pptx
 
blood and blood components therapy 1.ppt
blood and blood components therapy 1.pptblood and blood components therapy 1.ppt
blood and blood components therapy 1.ppt
 
Emerging and reemerging infections.ppt
Emerging and reemerging infections.pptEmerging and reemerging infections.ppt
Emerging and reemerging infections.ppt
 
PITUITARY DISORDERS.ppt
PITUITARY DISORDERS.pptPITUITARY DISORDERS.ppt
PITUITARY DISORDERS.ppt
 
Approach to stroke pt.pptx
Approach to stroke pt.pptxApproach to stroke pt.pptx
Approach to stroke pt.pptx
 
Addison's disease.ppt
Addison's disease.pptAddison's disease.ppt
Addison's disease.ppt
 
Alopecia by Essen .pptx
Alopecia by Essen .pptxAlopecia by Essen .pptx
Alopecia by Essen .pptx
 

Recently uploaded

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 

Haemoglobinopathies npmc.ppt

  • 1. HAEMOGLOBINOPATHIES: EMPHASIS ON SCA BAFFA A GWARAM MPH FMCP DEPT OF MEDICINE BUK/AKTH
  • 2. LEARNING OBJECTIVES Describe Haemoglobinopathies Describe the various complications and types of crisis in SCA and how to identify them. Understand the modalities of treatment of the various crises in our environment. Understand ways of preventing the crises.
  • 3. SESSION OUTLINE Introduction to Haemoglobinopathies Overview of SCD/SCA Complications of SCA Sickle Cell Crisis Management of SCA crises Prevention of sickle cell crises
  • 4. INTRODUCTION Haemoglobinopathies can be qualitative or quantitative Qualitative Hb abnormality due to alteration in DNA coding leading to an abn amino acid in the globin molecule Quantitative Hb disorders result from imbalance globin chain production Haemoglobinopathies result in significant morbidity and mortality on a world wide scale
  • 5. INTRODUCTION The clinical syndromes produced by Hb abnormalities: Syndrome Abnormality Haemolysis Crystalline Hb (S,C,D,E) Unstable Hb Thalassaemia α and β Familial polycythaemia Altered O2 affinity Methaemoglobinaemia Failure of reduction
  • 6. INTRODUCTION Thalassaemias α Thal - mostly due to gene deletion Silent α thal- (-α/αα) α thal trait (αα/-- or -α/-α) Hb H disease (--/-α) Hb Bart’s hydrops fetalis (--/--)
  • 7. INTRODUCTION β Thal – most are due to single point mutation -β+ reduced β globin synthesis -β0 absent β globin production Hence; β thal trait – carrier state β thal intermedia β thal major (Cooley’s anaemia)
  • 8. INTRODUCTION Crystalline Haemoglobins Hb S ( glu → val at position 6 ) Hb C ( glu → lys at position 6 ) Hb D ( glu → gln at position 121) Hb E ( glu → lys at position 26) Hb O ( glu → lys at position 121)
  • 9. James B. Africanus Horton (1835 - 1883) Nigerian born in Sierra Leone Qualified from the Medical School of King’s College London, at 24. In 1874, first to publish the features of SCD in his book ‘The Diseases of Tropical Climates & Their Treatment’. Research => MD Univ. of Edinburgh A Colonel in the British Army. A committed patriot, Horton was an advocate for the establishment of universities in West Africa.
  • 10. James B Herrick An interesting twist of history A Chicago Cardiologist In 1910, published the findings of ‘Peculiar elongated and sickled red blood cells in a case of severe anaemia’. 1st account of pathology of SCD. Gave SCD the name it bears today.
  • 11. OVERVIEW OF SCD/ SCA SCA is due to a point mutation in the β-globin gene. HbS differs from normal adult HbA by the substitution of valine for glutamic acid in the 6th position of the β-globin chain. This lead to polymerisation of deoxyHb S and instability of oxyHb S. Other abnormalities of β-chain synthesis may be inherited with Hb S, notably Hb C and the β thal. severity: Hb SS and HbS/β0 thal > HbSC > HbS/β+ thal
  • 12. OVERVIEW OF SCD/ SCA Hb SS is an example of mendelian inheritance. The disease course is significantly modified by envtal factors and other genes (β-globin haplotypes, HbF , α thal) Including genes controlling bilirubin, HTN, coagulation pathway, vascular cell adhesion molecule polymorphism, morphine receptor polymorphism
  • 13. OVERVIEW OF SCD/ SCA Epidemiology- Prevalence - 2% of SCA and 20-30% of the gene in Nigeria High frequency of HbS gene in area where P. falciparum is/was endemic, and in there emigrant population. HbS protects against P. Falciparum by atleast 2 mechanisms 1. Parasites consume O2 within the red cells, induce sickling and are removed by the RES in the early stages of erythrocytic cycle. 2. The last 12hrs of the parasite cycle are spent in deep tissue at low O2 tension
  • 14.
  • 15. ‘‘WE ARE SPECIAL PEOPLE WITH TOO MUCH OF A GOOD THING’’ - Hb SS patient
  • 16. OVERVIEW OF SCD/ SCA Pathogenesis When HbS is deoxygenated, the molecules of Hb polymerise to form tactoids. This distort the red cell membrane into sickle shaped cells. Sickling is initially reversible with reoxygenation. The distortion may become permanent and the red cell ’’irreversibly sickled’’
  • 17.
  • 18. COMPLICATIONS OF SCA In the homozygous state (HbSS) causes :- INFARCTION HAEMOLYTIC ANAEMIA That lead to ♦ Increase susceptibility to infections ♦ Disturbance of growth and dev ♦ Chronic organ damage
  • 19. COMPLICATIONS OF SCA Chronic anaemia leads to erythroid hyperplasia and expansion of the bone marrow which causes sickle cell facie ( bossing, depressed nasal bridge, gnathopathy). CVS – Tachycardia, mummurs. Heart is enlarged invariably after 6yrs GIT – Mod jaundice and raised serum bil, deranged LFT and fatty degeneration leading to liver failure. Pigment gallstones are found in about 10% of adult Nigerians. Hyposplenism
  • 20. Eye – Proliferative retinopathy, blindness, retinal artery occlusion, retinal detachment Genitourinary – Renal papillary necrosis leading to hematuria and renal tubular defect. Inability to concentrate urine, freq UTI in females and CKD in adults Locomotor – Avascular necrosis of the head of the femur or humerus, arthritis, osteomyelitis and chronic leg ulceration Pulmonary – chest pain due to pulm infarction, pneumonia. Chronic lung dx with cor pulmonale secondary to multiple arteriolar thrombi
  • 21. COMPLICATIONS OF SCA Infection – Impaired resistance to bacterial infection esp Strep. pneumoniae and salmonella spp because of :- ♦Inadequate opsonization ♦ Hyposplenism ♦ Lesions in skin, mucous memb and tissue necrosis following infarction ♦ Diminished CMI Acute viral infection are particularly severe HIV and Hep B&C infections
  • 22. COMPLICATIONS OF SCA CNS – Convulsions, TIAs or strokes, sensory hearing loss Psychosocial – Depression ,social withdrawal, drug addiction
  • 23. SICKLE CELL CRISIS Type of sickle cell crisis Anaemic Haemolytic Sequestration Aplastic Magaloblastic Infarctive
  • 24. SICKLE CELL CRISIS There are 4 types of anaemic crisis, during which the Hb concentration falls catastrophically: ♦ Haemolytic crisis cause severe anaemia and jaundice; they may follow infection e.g malaria, but often no trigger is identified. ♦ Sequestration crisis occur mainly in children. There is pooling of large volume of blood in the spleen or liver. Spleen enlarges dramatically and the Hb falls precipitously. ♦ Aplastic crisis is as a result of bone marrow depression by infection- particularly Parvovirus B19. Severe anaemia develops quickly.
  • 25. SICKLE CELL CRISIS ♦ Megaloblastic crisis. Almost all untreated African children with SCA are folate deficient and more than 10% of Africans with SCA have megaloblastic erythropoiesis due to folate deficiency.
  • 26. SICKLE CELL CRISIS Infarctive (Vaso-occlusive/Painful) crisis– Sickle cells do not flow well through small vessels and are more adherent than normal to vascular endothelium. They block the capillaries and cause infarction, with further endothelial damage and thrombosis. Necrosis of infarcted tissue leads to sudden swelling, severe pain and fever.
  • 27. SICKLE CELL CRISIS Infarctive crises are precipitated by factors that promote the deoxygenation of Hb in the capillaries, but in many instances no trigger is identified. Triggers – Infections, dehydration, exposure to cold , fatigue and stasis (menstruation). Dactilitis – In children between 6mths and 2yrs infarcts occur typically in the small bones of the hands and feet (in older children or adults the long bones are affected).
  • 28. SICKLE CELL CRISIS Stroke – Infarctive strokes are common in children while haemorrhagic stroke occur more in adults. Acute chest syndrome (ACS) – common cause of death. Chest wall pain, pleurisy, fever, cough and SOB. Has infitrates in the lungs. Resemble infection, infarction or embolism. Acute Bone Marrow Necrosis - Acute bone marrow necrosis is now recognized more often as a complication of sickle cell disease with the introduction of magnetic resonance imaging (MRI) techniques.
  • 29. SICKLE CELL CRISIS Any tissue of the body can be the site of an infarction:- ♦ Bony infarct (skull, ribs, long bones, spine and girdle) ♦ Splenic and hepatic infarcts ♦ Pulmonary micro infarcts ♦ Mesenteric infarcts ♦ Cortical or papillary infarcts Priapism is a potentially serious problem for young men with sickle cell disease. Priapism lasting more than three or four hours is a medical emergency since it can produce impotence.
  • 30. MANAGEMENT OF SCA CRISES Ideally patients should carry a sickle cell identity card. Take history Investigate – Hb (?steady state Hb), WCC and retics, thick and thin smear for MP. Examine urine and do other tests as indicated. Give a course of curative anti-malarial and continue with anti-malarial prophylaxis and folic acid
  • 31. MANAGEMENT OF SCA CRISES Anaemic crisis - Many patients whose Hb has fallen below their usual steady state level recover with no more than anti-malarial therapy, folic acid and antibiotics if indicated. Blood transfusion is indicated only if: ♦ The patient has respiratory distress ♦ The patient has incipient or actual cardiac failure ♦ There is a sequestration crisis the Hb is <6g/dl ♦ Obstetric delivery is imminent and Hb is < 8g/dl ♦ Major surgery is indicated and the Hb is < 8g/dl (Donor blood should be Hb AA)
  • 32. MANAGEMENT OF SCA CRISES Infarctive crisis – There is no specific treatment. ♦ Treat the cause if known; give appropriate antibiotics if infected ♦ Manage pain ♦ Maintain hydration and acid base balance; replace fluid liberally, either orally or IV ♦ Give O2 to patients with severe chest pain or pnuemonia
  • 33. MANAGEMENT OF SCA CRISES Management of pain -Severe pain- morphine in full therapeutic dose ± NSAID or promethazine -Less severe pain- Dihydrocodeine -Mild pain- Paracetamol ♦ Assess the severity of pain regularly :adjust doses accordingly ♦ Never prescribe analgesics ‘as required’ ♦ Give supply of PCM for self treatment ♦ Fentanyl patches are excellent for prolonged moderate to severe pain if available
  • 34. MANAGEMENT OF SCA CRISES Patients with SCA and unexplained fever should be cultured thoroughly. If the clinical condition suggests septicemia, the best action is to start broad spectrum antibiotics after complete culturing. Signs of systemic infection include fever, shaking chills, lethargy, malaise, and hypotension. Patients with septicemia can expire in only a few hours. Therefore, observation is not a good option when sepsis is suspected.
  • 35. MANAGEMENT OF SCA CRISES Stroke management includes rehydration and red cell transfusion, preferably exchange transfusion with the target of reducing HbS to 30% of total Hb. ACS requires prompt and vigorous treatment. Give O2 if pO2 can not be kept above 70mmHg on air. Treat infection, usually due to S. pneumoniae, H influenza, Mycoplasma, Legionella Exchange transfusion is the treatment of choice for ACS. The procedure involves exchange of the total blood volume and is done most efficiently using an apheresis machine.
  • 36. MANAGEMENT OF SCA CRISES The treatment of splenic sequestration crisis includes intravenous fluids and transfusion as necessary to maintain the intravascular volume. A child who suffers one episode of splenic sequestration crisis is at greater risk of a second attack . In hepatic sequestration, Fluids, oxygen and analgesia are the usual management interventions taken. The benefit of more aggressive measures such as exchange transfusion is unknown.
  • 37. MANAGEMENT OF SCA CRISES Patients with bone marrow necrosis often suffer excruciatingly severe pain. Some patients require epidural anesthesia for control of wrenchingly intense pain. Often, but not always, aplastic crisis coincide with a painful crisis. The reticulocyte count should be checked on admission to the hospital in patients with SCA. The treatment of aplastic crisis is purely supportive, with transfusions to maintain an acceptable hematocrit until marrow activity is restored.
  • 38. MANAGEMENT OF SCA CRISES Priapism- The most commonly used intervention in the past was irrigation of the ventral vein of the penis by a urologist in an attempt to remove the blockage to blood flow. Surgery often fail to resolve the priapism and has the risk of inducing impotence. More recently, exchange transfusion has been used in some of these patients with mixed results. Non-acute cases of priapism are sometimes treated with conjugated estrogens or vasodilators.
  • 39. PREVENTION OF CRISES Counseling Early diagnosis Education- General public, parents, guardians, patient, health professionals Sickle cell clinics ♦ Prevention of infection- anti-malarial prophylaxis, ITNs, prophylactic oral penicillin, Pneumococcal vaccine, H influenza vaccine, all routine vaccines.
  • 40. PREVENTION OF CRISIS Sickle cell clinics (cont) ♦ Nutrition- Folic acid and oral zinc supplements, Gen nutritional advice ♦ Self treatment – PCM ♦ Advice- Avoid triggers of crises, attend clinic regularly, report when ill and when pregnant
  • 41. PREVENTION OF CRISIS Obstetric care – Prenatal diagnosis ANC booking early Anti-malarial Folic acid Monitor- Hb, BP, Urine protein Deliver in hospital Supervision of puerperium- monitor for infection ♦ Family limitation- advice not more than two viable children
  • 42. PREVENTION OF CRISIS Recent therapeutic advances Hydroxyurea Erythropoietin Short chain fatty acids-Isobutyramide Clotrimazole 5-azacytidine Transcranial doppler Bone marrow transplantation Gene therapy Extended matching for red cell antigens for blood transfusion
  • 43. HYDROXYUREA THERAPY Studies have shown that both sickled and unsickled RBCs attach to vascular endothelium using adhesion molecules So, RBCs also contribute to vaso-occlusion in SCD through an active process distinct from passive mechanical obstruction.
  • 44. Molecules That Mediate RBC Adherence to Vascular Endothelium.
  • 45. HYDROXYUREA THERAPY α5ß3 integrin on vascular endothelium is the ligand for several RBC adhesion molecules; e.g, phosphatidylserine, sulfated glycans, CD47 & CD36. Administration of a monoclonal antibody to α5ß3 integrin abolished vaso-occlusion in a mouse model with SCD. Therefore, α5ß3 integrin is a candidate cell adhesion molecule for targeted reduction or blockage in the treatment of SCD.
  • 46. Evidence That WBCs Have A Role In SCD The Severity of SCD Increases With Neutrophil Count High WBC Count: A Risk Factor For Early Death Clinical Improvement During Hydroxyurea Therapy Coincides with Fall in WBC Count, even without a rise in HbF. Sickle Cell Crisis & Acute Chest Syndrome Following Severe Neutrophilia Induced By G-CSF; Resolved As Hydroxyurea Therapy Brought Down WBC Count. High Neutrophil Count: A Powerful Predictor of Good Response to Hydroxyurea
  • 47. References Fleming AF,Menedez C: Blood in ;Principleof medicine in Africa; Parry E et al (editors), 3rd edition.p 924-70 Cambridge publishing. Provan D et al (editors):Oxford hand book of clinical haematology,2nd edition. P72-84 Oxford publishing Young NS, Stanton LG, High KA (editors): Clinical haematology, 2nd edition. Mosby Elsevier publishing Halett C et al(editors): Davidson’s principle and practice of medicine 19th edition. P737-800 Churchill Livingstone publishing